translates into diagnostic tests that provide physicians with biologically informative data, enabling them to personalize cancer treatment plans (precision oncology). By avoiding unnecessary surgeries, and treatments, QDx not only improves patient outcomes but also reduces healthcare costs. Our cloud-based platform facilitates global deployment of these tests in an asset-light manner, along with our central marketplace that streamlines test selection, ordering, and data exchange for all stakeholders. The central marketplace is a licensable SaaS solution to power the widespread adoption of precision oncology tests, seamlessly connection patients to the ever-evolving world of molecular diagnostics. Ultimately, QDx empowers physicians, patients, and other test developers with actionable insights, leading to a more effective and efficient approach to cancer care.